AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33246021 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib (300 mg/day) plus fulvestrant (500 mg every 28 days and once on day 15)
Number of subjects: 341
Study 33246021 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 341
Study 33246021 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib-fulvestrant
Number of subjects: 341
Study 33246021 — intervention group
Group type: COMPARATOR
Intervention: Placebo-fulvestrant
Number of subjects: 341
Study 35879534 — intervention group
Group type: EXPERIMENTAL
Intervention: HL6 measure via text messaging
Number of subjects: 306
Study 35879534 — intervention group
Group type: COMPARATOR
Intervention: HL6 measure via online survey
Number of subjects: 306
Study 35879534 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher HL6 scores
Number of subjects: 306
Study 34174474 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS treatment
Number of subjects: 36
Study 34174474 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 36
Study 32586583 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 1240
Study 35750737 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 2 grams preoperatively
Number of subjects: 470
Study 35750737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 470
Study 34836081 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 278
Study 34836081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean/low-carbohydrate diet
Number of subjects: 278
Study 34836081 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 278
Study 34836081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical-SAT reduction
Number of subjects: 278
Study 32211778 — intervention group
Group type: EXPERIMENTAL
Intervention: Wind turbine noise (WTN) at 32 dB LAEq during sleep nights
Number of subjects: 50
Study 32211778 — intervention group
Group type: COMPARATOR
Intervention: Control (quiet night)
Number of subjects: 50
Study 32211778 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported sleep quality
Number of subjects: 50
Study 35750588 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute scripted phone call from a physician 3–4 days after embryo transfer
Number of subjects: 231
Study 35750588 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 231
Study 33988549 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 93
Study 33988549 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection
Number of subjects: 93
Study 33988549 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 93
Study 33988549 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk features
Number of subjects: 93
Study 36250662 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept
Number of subjects: 84
Study 36250662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 36250662 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept (bailout)
Number of subjects: 84
Study 33217822 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic B‐SES
Number of subjects: 10
Study 33217822 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study 33010323 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment
Number of subjects: 114
Study 33010323 — intervention group
Group type: COMPARATOR
Intervention: Ciclopiroxolamine 1% cream
Number of subjects: 114
Study 33002553 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg/day with Metformin 1000 mg/day
Number of subjects: 80
Study 36309760 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN) starting on postoperative day (POD) 1 at 200-300 ml/day, increased to 400-600 ml/day on POD 2, depending on surgeon's decision from POD 3.
Number of subjects: 320
Study 36309760 — intervention group
Group type: COMPARATOR
Intervention: Peripheral Parental Nutrition (PPN) delivered after surgery.
Number of subjects: 320
Study 36309760 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups start oral feeding on POD 3.
Number of subjects: 320
Study 34328151 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of Salmon milt peptide (SMP) administered continuously or as a single dose for one week
Number of subjects: 14
Study 34328151 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not explicitly detailed in the abstract)
Number of subjects: 14
Study 36164011 — intervention group
Group type: EXPERIMENTAL
Intervention: Rusfertide (10-120 mg weekly)
Number of subjects: 0
Study 36164011 — intervention group
Group type: EXPERIMENTAL
Intervention: Rusfertide (40 mg SQ twice weekly)
Number of subjects: 0
Study 36164011 — intervention group
Group type: COMPARATOR
Intervention: Rusfertide interruption
Number of subjects: 0
Study 36164011 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinitiating rusfertide
Number of subjects: 0
Study 33119898 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax plus azacitidine (AZA; 75 mg/m2; days 1-7)
Number of subjects: 0
Study 33119898 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax plus decitabine (DEC; 20 mg/m2; days 1-5)
Number of subjects: 0
Study 33119898 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax plus azacitidine (AZA) and decitabine (DEC)
Number of subjects: 0
Study 32771105 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy for peanut allergy
Number of subjects: 0
Study 35460273 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscope-assisted post-auricular sulcus incision
Number of subjects: 45
Study 35460273 — intervention group
Group type: COMPARATOR
Intervention: Conventional Blair 'S' incision
Number of subjects: 45
Study 34499961 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress condition (Trier Social Stress Test, TSST)
Number of subjects: 51
Study 34499961 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 51
Study 35445687 — intervention group
Group type: EXPERIMENTAL
Intervention: Latin dance program (4-month duration, followed by a 4-month maintenance program)
Number of subjects: 333
Study 35445687 — intervention group
Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 333
Study 32578472 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day intake of NZBC extract (600 mg containing 210 mg of anthocyanins)
Number of subjects: 16
Study 32578472 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day intake of NZBC extract (600 mg containing 210 mg of anthocyanins)
Number of subjects: 16
Study 33058991 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative oxygen therapy
Number of subjects: 429
Study 33058991 — intervention group
Group type: COMPARATOR
Intervention: Liberal oxygen therapy
Number of subjects: 429
Study 34718239 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-phase UC
Number of subjects: 30
Study 34718239 — intervention group
Group type: EXPERIMENTAL
Intervention: Remission-phase UC
Number of subjects: 30
Study 34718239 — intervention group
Group type: COMPARATOR
Intervention: Control (Irritable bowel syndrome)
Number of subjects: 30
Study 33112049 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazelnut oil containing 24.2 mg kg‐1 2‐MCPD and 54.5 mg kg‐1 3‐MCPD
Number of subjects: 12
Study 33112049 — intervention group
Group type: COMPARATOR
Intervention: Background excretion before exposure
Number of subjects: 12
Study 32282696 — intervention group
Group type: EXPERIMENTAL
Intervention: HAL‐RAR with Doppler US navigation
Number of subjects: 204
Study 32282696 — intervention group
Group type: COMPARATOR
Intervention: HAL with manual HA detection and mucopexy
Number of subjects: 204
Study 32888828 — intervention group
Group type: EXPERIMENTAL
Intervention: Geranium aromatherapy
Number of subjects: 150
Study 32888828 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 150
Study 32888828 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study 34192759 — intervention group
Group type: EXPERIMENTAL
Intervention: Theracal
Number of subjects: 60
Study 34192759 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 60
Study 34192759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dycal
Number of subjects: 60
Study 35285428 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (eight sessions)
Number of subjects: 120
Study 35285428 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study 33546610 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation (ONS) combined with sit-to-stand (STS) exercises for 12 weeks
Number of subjects: 0
Study 616791867 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS‐102 35 mg/m² orally twice daily after meals on days 1 through 5 and 8 through 12 of each 28‐day cycle (n = 534)
Number of subjects: 800
Study 616791867 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 266)
Number of subjects: 800
Study 616791867 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS‐102 35 mg/m²
Number of subjects: 800
Study 33749531 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Scale for Suicide Ideation (BSS)
Number of subjects: 141
Study 33749531 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicidal Behaviors Questionnaire‐Revised (SBQ‐R)
Number of subjects: 141
Study 33749531 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Injurious Thoughts and Behaviors Interview‐Short Form (SITBI‐SF)
Number of subjects: 141
Study 33749531 — intervention group
Group type: EXPERIMENTAL
Intervention: Inconsistent Responders
Number of subjects: 141
Study 34560686 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (n = 265)
Number of subjects: 501
Study 34560686 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy (n = 269)
Number of subjects: 501
Study 33925049 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% whole grain cereals with 12 g sugar (50-WG)
Number of subjects: 43
Study 33925049 — intervention group
Group type: COMPARATOR
Intervention: 0% whole grain cereals with 24 g sugar (0-WG)
Number of subjects: 43
Study 32065303 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG followed by TFV
Number of subjects: 30
Study 32065303 — intervention group
Group type: COMPARATOR
Intervention: TFV alone
Number of subjects: 30
Study 36030401 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (three 50-min sessions each week at 70% maximal power for 8 weeks)
Number of subjects: 17
Study 36030401 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 17
Study 36030401 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control period
Number of subjects: 17
Study 33788461 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion combined with western medication
Number of subjects: 60
Study 33788461 — intervention group
Group type: COMPARATOR
Intervention: Simple western medication (alendronate sodium tablet, calcium carbonate, vitamin D3 tablet)
Number of subjects: 60
Study 33437034 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselors communicating the essence of uncertainty and providing information
Number of subjects: 224
Study 33437034 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive information
Number of subjects: 224
Study 33437034 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor using information providing responses
Number of subjects: 224
Study 32376347 — intervention group
Group type: EXPERIMENTAL
Intervention: VSI (video + manikin)
Number of subjects: 1325
Study 32376347 — intervention group
Group type: COMPARATOR
Intervention: mApp (video, no manikin)
Number of subjects: 1325
Study 32376347 — intervention group
Group type: COMPARATOR
Intervention: Comparison of mApp to VSI
Number of subjects: 1325
Study 34902838 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular Tandem Walk Test (CTWT)
Number of subjects: 89
Study 34902838 — intervention group
Group type: EXPERIMENTAL
Intervention: CTWT time to perform ≥ 14.6 seconds
Number of subjects: 89
Study 34902838 — intervention group
Group type: EXPERIMENTAL
Intervention: CTWT with ≥ two error scores
Number of subjects: 89
Study 33404668 — intervention group
Group type: EXPERIMENTAL
Intervention: Osgood Schlatter disease (OSD) group
Number of subjects: 171
Study 33404668 — intervention group
Group type: COMPARATOR
Intervention: Control group (without OSD)
Number of subjects: 171
Study 34252203 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 L of balanced hypotonic electrolyte supplement
Number of subjects: 8
Study 34252203 — intervention group
Group type: COMPARATOR
Intervention: 1 to 3 L of water
Number of subjects: 8
Study 34252203 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 L of balanced hypotonic electrolyte supplement with 42K
Number of subjects: 8
Study 34252203 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyte supplementation
Number of subjects: 8
Study 34252203 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotracer 24Na+ and 42K+
Number of subjects: 8
Study 34252203 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise Na+ and K+ levels
Number of subjects: 8
Study 35867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (CSI)
Number of subjects: 60
Study 35867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendon needling (TN)
Number of subjects: 60
Study 35867777 — intervention group
Group type: COMPARATOR
Intervention: Placebo needling (PN)
Number of subjects: 60
Study 34682309 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 64)
Number of subjects: 82
Study 34682309 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n = 18)
Number of subjects: 82
Study 32618385 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-management programme (WW) for 12 weeks
Number of subjects: 1267
Study 32618385 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-management programme (WW) for 52 weeks
Number of subjects: 1267
Study 32618385 — intervention group
Group type: COMPARATOR
Intervention: Brief intervention (BI; self-help booklet)
Number of subjects: 1267
Study 36050227 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 4796
Study 36050227 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study 33863751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemia treatment
Number of subjects: 0
Study 33863751 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 35396860 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympatex glove underneath a cotton glove (SYM/COT)
Number of subjects: 199
Study 35396860 — intervention group
Group type: COMPARATOR
Intervention: Cotton glove (COT)
Number of subjects: 199
Study 35396860 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SYM/COT and COT
Number of subjects: 199
Study 32653397 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with antenatal care
Number of subjects: 287
Study 32653397 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding the information provided by health professionals during labor and delivery
Number of subjects: 287
Study 32653397 — intervention group
Group type: EXPERIMENTAL
Intervention: Not having reported disrespect and abuse
Number of subjects: 287
Study 32653397 — intervention group
Group type: EXPERIMENTAL
Intervention: Having had the baby put to the breast within the first hour of life
Number of subjects: 287
Study 35213517 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg E2/100 mg P4
Number of subjects: 157
Study 35213517 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg E2/100 mg P4
Number of subjects: 157
Study 35213517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 32510250 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular carotid baroreflex amplification device
Number of subjects: 0
Study 32510250 — intervention group
Group type: COMPARATOR
Intervention: Sham-controlled renal nerve denervation
Number of subjects: 0
Study 33420480 — intervention group
Group type: EXPERIMENTAL
Intervention: OCPs (0.15 mg levonorgestrel + 0.30 μg ethinyl estradiol)
Number of subjects: 26
Study 33420480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 33420480 — intervention group
Group type: EXPERIMENTAL
Intervention: OCPs
Number of subjects: 26
Study 32678321 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration ≥8 hours per day
Number of subjects: 14485
Study 32678321 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor sleep quality
Number of subjects: 14485
Study 32678321 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration ≥8 hours and/or poor sleep quality
Number of subjects: 14485
Study 36346544 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 90
Study 36346544 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam plus dexmedetomidine
Number of subjects: 90
Study 36346544 — intervention group
Group type: COMPARATOR
Intervention: Propofol control
Number of subjects: 90
Study 36346544 — intervention group
Group type: COMPARATOR
Intervention: Remimazolam, Remimazolam plus dexmedetomidine, Propofol control
Number of subjects: 90
Study 33526623 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + pred (methotrexate with prednisone)
Number of subjects: 0
Study 33526623 — intervention group
Group type: COMPARATOR
Intervention: MTX + PBO (methotrexate with placebo)
Number of subjects: 0
Study 36258179 — intervention group
Group type: EXPERIMENTAL
Intervention: group version of the Lifestyle-integrated Functional Exercise program (gLiFE)
Number of subjects: 237
Study 36258179 — intervention group
Group type: COMPARATOR
Intervention: individually delivered version (LiFE)
Number of subjects: 237
Study 33676071 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFE Face-to-face intervention
Number of subjects: 90
Study 33676071 — intervention group
Group type: EXPERIMENTAL
Intervention: SAFE Computer-adapted intervention
Number of subjects: 90
Study 33676071 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 90
Study 34962164 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop control system (CLC)
Number of subjects: 35
Study 32799056 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy messages
Number of subjects: 320
Study 32799056 — intervention group
Group type: EXPERIMENTAL
Intervention: Threat/efficacy messages
Number of subjects: 320
Study 32799056 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study 34740588 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS pediatric measures
Number of subjects: 266
Study 33587132 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal coordinated care intervention including ≥3 APC clinic visits, ≥3 CHW home visits, Chronic Disease Self‐Management Program workshops, additional telephone visits, protocol‐driven risk factor management, culturally and linguistically tailored education materials, and self‐management tools.
Number of subjects: 487
Study 33587132 — intervention group
Group type: COMPARATOR
Intervention: Usual care, which varied by site but frequently included a free BP monitor, self‐management tools, and linguistically tailored information materials.
Number of subjects: 487
Study 32992020 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (Breathing and Attention Training, BAT) combined with transcranial direct current stimulation (tDCS)
Number of subjects: 0
Study 32992020 — intervention group
Group type: COMPARATOR
Intervention: Sham BAT combined with Sham tDCS
Number of subjects: 0
Study 32992020 — intervention group
Group type: EXPERIMENTAL
Intervention: Real BAT combined with Sham tDCS
Number of subjects: 0
Study 32992020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham BAT combined with Real tDCS
Number of subjects: 0
Study 33225772 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy plus UDCA (10 mg/kg/day)
Number of subjects: 220
Study 33225772 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy (Control group)
Number of subjects: 220
Study 32507929 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid response (RR)
Number of subjects: 210
Study 32507929 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ED pathology
Number of subjects: 210
Study 32240122 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 126
Study 32240122 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 126
Study 36026684 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural MRI scan of the heart and 3D printing of left atrium and pulmonary veins with cryoablation
Number of subjects: 100
Study 36026684 — intervention group
Group type: COMPARATOR
Intervention: Standard cryoablation without imaging
Number of subjects: 100
Study 32875451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate peel supplementation via water (0.3 g L‐1)
Number of subjects: 240
Study 32875451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate peel supplementation via diet (1 g PP powder/kg diet)
Number of subjects: 240
Study 32875451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate peel supplementation via diet (2 g PP powder/kg diet)
Number of subjects: 240
Study 32875451 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 240
Study 32875451 — intervention group
Group type: COMPARATOR
Intervention: Positive control (Hg exposure, basal diet)
Number of subjects: 240
Study 32875451 — intervention group
Group type: EXPERIMENTAL
Intervention: Hg + Pomegranate peel supplementation via water (0.3 g L‐1)
Number of subjects: 240
Study 32875451 — intervention group
Group type: EXPERIMENTAL
Intervention: Hg + Pomegranate peel supplementation via diet (1 g PP powder/kg diet)
Number of subjects: 240
Study 32875451 — intervention group
Group type: EXPERIMENTAL
Intervention: Hg + Pomegranate peel supplementation via diet (2 g PP powder/kg diet)
Number of subjects: 240
Study 34657655 — intervention group
Group type: EXPERIMENTAL
Intervention: Rezum
Number of subjects: 0
Study 34657655 — intervention group
Group type: EXPERIMENTAL
Intervention: UroLift
Number of subjects: 0
Study 32029429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical injection of 99m Tc at the 3 and 9 o'clock positions of the uterine cervix
Number of subjects: 81